The Cannabist Company Holdings Inc. announced that, effective immediately, the Company?s Board of Directors appointed David Hart, previously the Company?s President and Chief Operating Officer, as the new Chief Executive Officer. Nicholas Vita will continue to serve as a Director of the Company. Vita co-founded The Cannabist Company, formerly Columbia Care, in 2012 when he became the Company?s first employee.

He has served as its Chief Executive Officer since then. Under his leadership, the Company has grown to thousands of employees, encompasses 16 fully integrated markets in the U.S., generates more than $500 million in annual revenue, went public on a senior exchange in Canada, and serves countless patients and customers with high-quality products across the national portfolio. David Hart joined The Cannabist Company in 2016 and became Chief Operating Officer in 2018.

Prior to joining The Cannabist Company, David served as Chief Operating Officer of Abyrx, a venture capital-backed medical device company that developed, manufactured, and commercialized a portfolio of intraoperative cross specialty hemostats. Prior to his time at Abyrx, David was Chief Financial Officer and Chief Investment Officer at Alpine Capital, a family investment office for the Ranawat Orthopedic Group at the Hospital for Special Surgery, where he was responsible for capital allocations, direct private investments, and all healthcare investments. David was also previously the Partner and Head of Healthcare Equity Investments at Apelles Investment Management.

David started his career in the financial services industry in the Mergers and Acquisitions groups at Thomas Weisel Partners and Duff & Phelps. David has an MBA from Columbia University and is a graduate of Duke University.